The rare individual who might consider this combination needs exceptional GI tolerance proven on prior GLP-1s, physician supervision with frequent monitoring, ability to afford $15,000-30,000 annually, understanding they're experimenting on themselves, and willingness to stop immediately if severe side effects emerge
Research shows systemic effects require milligram-range dosing for GHK-Cu, while BPC-157 and TB-500 show activity at lower concentrations
Interest in BPC-157 has grown due to encouraging preclinical research and its increasing use within functional and regenerative medicine programs
Available from: diabetesatlas.org Zou H, Xie L, Hu J, Zhang R, Wang Y, Xu A et al (2025) Fatty acid binding protein 4 regulates the antigen-presenting function of dendritic cells resulting in T cell priming in streptozotocin-induced type 1 diabetes mice
Sidorenko, Irina D
What is Glutathione Treatment